Sun to pay $3.2 billion for Ranbaxy, will be world No. 5

India's most valuable pharmaceutical company, Sun Pharma, has agreed to buy Ranbaxy Laboratories, plagued with multiple product quality issues, from Japan's Daiichi Sankyo in an all-share transaction totalling $3.2 billion.

Read Full Story>>